Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS-233 SR for menopausal vasomotor symptoms
2004-005022-45Phase 3Completed
- Sponsor
- Wyeth
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of desvenlafaxine in vasomotor symptoms (3 arms), sponsored by Wyeth. Started Feb 2005; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on 2004-005022-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005022-45.